Functional Outcomes and Quality of Life After Proximal Gastrectomy with Esophagogastrostomy Using a Narrow Gastric Conduit
The best surgical approach for tumors of the proximal stomach remains controversial. For proximal gastrectomy (PG), the evidence regarding quality of life (QoL) and functional outcomes is controversial. Moreover, there are limited data from non-Asian settings.
All patients who underwent PG from September 2005 to July 2013 were identified from an institutional database. Demographic, perioperative and pathologic characteristics were retrieved. Symptom scores (0 = best/4 = worst) for reflux symptoms, dysphagia and validated QoL metrics (FACT scale, where a higher score is better) were assessed during early and late follow-up. Eligible patients for analysis were those with no evidence of recurrence.
Of 465 upper gastrointestinal cancer resections, 50 were PG for adenocarcinoma (42; 84 %), neuroendocrine carcinoma (5; 10 %) or other pathologies (3; 6 %). R0 resection was achieved in 44 (89.8 %) of 49 patients with malignant tumors. Median lymph node collection was 32 (range 7–57). QoL scores did not differ from preoperative to early follow-up but increased compared to both at late follow-up [preoperative, 125 (interquartile range 105–140); early follow-up, 122.5 (97–142); late follow-up, 147 (132–159); p < 0.05]. At early and late follow-up, 9 (21.4 %) of 42 and 10 (33.3 %) of 30 patients reported reflux symptoms, but most were mild. Endoscopic signs of esophagitis were found in 7 (29 %) of 24 patients, but only two of these reported reflux symptoms. Conversely only three of eight patients with reflux symptoms had esophagitis on endoscopy.
Global QoL is not reduced early after PG, and increases compared to baseline at late follow-up. Although reflux symptoms are reported by a quarter of patients, most are mild, and there is little correlation with esophagitis. PG should remain a viable option in the management of proximal gastric tumors.
KeywordsEsophagitis Total Gastrectomy Reflux Symptom Proximal Stomach Proximal Gastrectomy
UR was supported by a fellowship within the Postdoc-Program of the German Academic Exchange Service (DAAD).
- 3.Maruyama K, Gunven P, Okabayashi K, Sasako M, Kinoshita T. Lymph node metastases of gastric cancer. General pattern in 1931 patients. Ann Surg. 1989;5:596–602.Google Scholar
- 4.ESMO/European Sarcoma Network Working Group. Gastrointestinal stromal tumors: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2012;23(Suppl 7):vii49–55.Google Scholar
- 20.Siewert JR, Holscher AH, Becker K, Gossner W. Cardia cancer: attempt at a therapeutically relevant classification. Chirurg. 1987;1:25–32.Google Scholar
- 23.Cella DF, Tulsky DS, Gray G, et al. The functional assessment of cancer therapy scale: development and validation of the general measure. J Clin Oncol. 1993;3:570–9.Google Scholar
- 28.National Comprehensive Cancer Network. Clinical practice guidelines in oncology. Esophageal and esophagogastric junction cancers. Version 2.2013.Google Scholar
- 32.Hsu CP, Chen CY, Hsieh YH, Hsia JY, Shai SE, Kao CH. Esophageal reflux after total or proximal gastrectomy in patients with adenocarcinoma of the gastric cardia. Am J Gastroenterol. 1997;8:1347–50.Google Scholar
- 33.Matei D, Dadu R, Prundus R, et al. Alkaline reflux esophagitis in patients with total gastrectomy and Roux en Y esojejunostomy. J Gastrointestin Liver Dis. 2010;3:247–52.Google Scholar